Related Experiment Video
Updated: Jun 24, 2026
13:00
Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
Published on: July 31, 2021
Immunization in pregnancy: No. 220, December 2008.
Summary
This review provides recommendations for safe and effective immunization in pregnancy. Following these guidelines ensures appropriate vaccination for pregnant and breastfeeding women, enhancing disease prevention.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Preventive Health Care
Background:
- Immunization during pregnancy is crucial for maternal and fetal health.
- Evidence-based recommendations are needed to guide clinical practice.
- Ensuring appropriate vaccination reduces risks associated with preventable diseases.
Purpose of the Study:
- To review existing evidence on immunization in pregnancy.
- To provide updated recommendations for vaccination of pregnant and breastfeeding women.
- To enhance disease prevention strategies in this population.
Main Methods:
- A comprehensive literature search of Medline and Cochrane databases was conducted up to June 2007.
- Evidence was systematically reviewed and evaluated by the Society of Obstetricians and Gynaecologists of Canada (SOGC) Infectious Diseases Committee.
- Recommendations were formulated based on guidelines from the Canadian Task Force on Preventive Health Care.
Main Results:
- The review evaluated the effectiveness of various immunizations.
- Risks and benefits of immunization for both mother and fetus were assessed.
- The evidence supports specific immunization protocols for pregnant women.
Conclusions:
- Implementation of these recommendations will lead to more appropriate immunization practices.
- This will decrease the incidence of contraindicated immunizations.
- Improved disease prevention in pregnant and breastfeeding women is expected.
Related Concept Videos
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:51Vaccinations
Overview
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:31Active versus Passive Immunity
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...